NCT00344175

Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors

Double-blind follow-on Study of Pitavastatin (4mg) Versus Simvastatin (40mg and 80mg) With a Single-blind Extension of Treatment in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia and 2 or More Risk Factors for Coronary Heart Disease

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 178 (actual)
• Sponsor: Kowa Research Europe · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a sixteen-week follow-on and 28 week single-blind extension study for patients who participated in study NK-104-304.

Detailed description

This is a sixteen-week, double-blind, active controlled, follow-on and 28 week single blind extension study for patients who participated in NK-104-304.

Conditions

• Hypercholesterolemia
• Dyslipidemia
• Coronary Heart Disease

Interventions

Type	Name	Description
DRUG	pitavastatin
DRUG	simvastatin

Timeline

• Start date: 2006-06-01
• Primary completion: 2007-08-01
• Completion: 2007-08-01
• First posted: 2006-06-26
• Last updated: 2010-02-02
• Results posted: 2010-01-18

Locations

28 sites across 4 countries: Denmark, Netherlands, Spain, Sweden